1887

Abstract

Hepatitis B virus (HBV) is one of the world's major unconquered infections, resulting in progressive liver disease, and current treatments rarely cure infection. A limitation to discovering new therapies is our limited knowledge of HBV entry and dissemination pathways that hinders the development of culture systems. To address this gap in our understanding we optimized the genesis of infectious lentiviral pseudoparticles (HBVpps). The recent discovery that the bile salt transporter sodium taurocholate co-transporting polypeptide (NTCP) acts as a receptor for HBV enabled us to assess the receptor dependency of HBVpp infection. HBVpps preferentially infect hepatoma cells expressing NTCP, whereas other non-liver cells engineered to express NTCP do not support infection, suggesting that additional hepatocyte-specific factors are required for HBVpp internalization. These results highlight the value of the HBVpp system to dissect the pathways of HBV entry and dissemination.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000317
2016-01-01
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/1/121.html?itemId=/content/journal/jgv/10.1099/jgv.0.000317&mimeType=html&fmt=ahah

References

  1. Baumert T. F., Meredith L., Ni Y., Felmlee D. J., McKeating J. A., Urban S.. ( 2014;). Entry of hepatitis B and C viruses – recent progress and future impact. Curr Opin Virol 4: 58–65 [CrossRef] [PubMed].
    [Google Scholar]
  2. Billioud G., Pichoud C., Parent R., Zoulim F.. ( 2012;). Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutants. J Hepatol 56: 1269–1275 [CrossRef] [PubMed].
    [Google Scholar]
  3. Chai N., Chang H. E., Nicolas E., Gudima S., Chang J., Taylor J.. ( 2007;). Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes. J Virol 81: 10897–10904 [CrossRef] [PubMed].
    [Google Scholar]
  4. El-Serag H. B.. ( 2012;). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142: 1264–1273 [CrossRef] [PubMed].
    [Google Scholar]
  5. Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C. M., McKeating J. A.. ( 2003;). Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A 100: 7271–7276 [CrossRef] [PubMed].
    [Google Scholar]
  6. Locarnini S. A., Yuen L.. ( 2010;). Molecular genesis of drug-resistant and vaccine-escape HBV mutants. Antivir Ther 15: 451–461 [CrossRef] [PubMed].
    [Google Scholar]
  7. Moller-Tank S., Maury W.. ( 2015;). Ebola virus entry: a curious and complex series of events. PLoS Pathog 11: e1004731 [CrossRef] [PubMed].
    [Google Scholar]
  8. Ni Y., Lempp F. A., Mehrle S., Nkongolo S., Kaufman C., Fälth M., Stindt J., Königer C., Nassal M., other authors. ( 2014;). Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 146: 1070–1083 [CrossRef] [PubMed].
    [Google Scholar]
  9. Oehler N., Volz T., Bhadra O. D., Kah J., Allweiss L., Giersch K., Bierwolf J., Riecken K., Pollok J. M., other authors. ( 2014;). Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism. Hepatology 60: 1483–1493 [CrossRef] [PubMed].
    [Google Scholar]
  10. Peng L., Zhao Q., Li Q., Li M., Li C., Xu T., Jing X., Zhu X., Wang Y., other authors. ( 2015;). The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B. Hepatology 61: 1251–1260 [CrossRef] [PubMed].
    [Google Scholar]
  11. Reese V. C., Oropeza C. E., McLachlan A.. ( 2013;). Independent activation of hepatitis B virus biosynthesis by retinoids, peroxisome proliferators, and bile acids. J Virol 87: 991–997 [CrossRef] [PubMed].
    [Google Scholar]
  12. Sung V. M., Lai M. M.. ( 2002;). Murine retroviral pseudotype virus containing hepatitis B virus large and small surface antigens confers specific tropism for primary human hepatocytes: a potential liver-specific targeting system. J Virol 76: 912–917 [CrossRef] [PubMed].
    [Google Scholar]
  13. Tang H., Banks K. E., Anderson A. L., McLachlan A.. ( 2001;). Hepatitis B virus transcription and replication. Drug News Perspect 14: 325–334 [PubMed].
    [Google Scholar]
  14. Temperton N. J., Hoschler K., Major D., Nicolson C., Manvell R., Hien V. M., Ha Q., de Jong M., Zambon M., other authors. ( 2007;). A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir Viruses 1: 105–112 [CrossRef] [PubMed].
    [Google Scholar]
  15. Thomas D., Zoulim F.. ( 2012;). New challenges in viral hepatitis. Gut 61: (Suppl 1), i1–i5 [CrossRef] [PubMed].
    [Google Scholar]
  16. Verrier E. R., Colpitts C. C., Bach C., Heydmann L., Weiss A., Renaud M., Durand S. C., Habersetzer F., Durantel D., other authors. ( 2015;). [CrossRef] [Epub ahead of print] A targeted functional RNAi screen uncovers Glypican 5 as an entry factor for hepatitis B and D viruses. Hepatology.
    [Google Scholar]
  17. Volz T., Allweiss L., Ben MBarek M., Warlich M., Lohse A. W., Pollok J. M., Alexandrov A., Urban S., Petersen J., other authors. ( 2013;). The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. J Hepatol 58: 861–867 [CrossRef] [PubMed].
    [Google Scholar]
  18. Wright E., McNabb S., Goddard T., Horton D. L., Lembo T., Nel L. H., Weiss R. A., Cleaveland S., Fooks A. R.. ( 2009;). A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa. Vaccine 27: 7178–7186 [CrossRef] [PubMed].
    [Google Scholar]
  19. Yan H., Zhong G., Xu G., He W., Jing Z., Gao Z., Huang Y., Qi Y., Peng B., other authors. ( 2012;). Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1: e00049 [CrossRef] [PubMed].
    [Google Scholar]
  20. Zimmer G., Locher S., Berger Rentsch M., Halbherr S. J.. ( 2014;). Pseudotyping of vesicular stomatitis virus with the envelope glycoproteins of highly pathogenic avian influenza viruses. J Gen Virol 95: 1634–1639 [CrossRef] [PubMed].
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000317
Loading
/content/journal/jgv/10.1099/jgv.0.000317
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error